Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
12/15/2009 | US7632813 Administering N-(3-{2-[3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-tetrahydro-2H-pyran-4-ylpropyl)cycloheptanecarboxamideas an inhibitor and a type of parathyroid hormone to treat and/orprevent bone metabolic diseases |
12/15/2009 | US7632808 Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system |
12/15/2009 | US7632528 Simple and effective method for the prophylactic treatment of migraine substantially free of any side effects such as damage/irritation to the nasal mucosa membrane |
12/15/2009 | CA2481459C A pharmaceutical composition for treating rheumatism and the preparation thereof |
12/15/2009 | CA2403110C N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them |
12/15/2009 | CA2373180C Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
12/15/2009 | CA2345138C Polymer conjugates of interferon beta-1a and their uses |
12/15/2009 | CA2334189C Bridged indenopyrrolocarbazoles |
12/15/2009 | CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof |
12/15/2009 | CA2209315C Gibberellins compounds for veterinary and medicinal applications |
12/10/2009 | WO2009149279A2 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
12/10/2009 | WO2009148599A1 Pyrrole compunds that modulate hsp90 activity |
12/10/2009 | WO2009147742A1 Sirna of human osteopontin |
12/10/2009 | WO2009147442A1 Novel treatments |
12/10/2009 | WO2009147326A1 Analgesic effects of peptide toxin apetx2 |
12/10/2009 | WO2009147269A1 Topical ibuprofen formulation |
12/10/2009 | WO2009147188A1 Benzpyrazol derivatives as inhibitors of pi3 kinases |
12/10/2009 | WO2009147187A1 4-carboxamide indazole derivatives useful as inhibitors of p13-kinases |
12/10/2009 | WO2009147079A1 3,4-dihydropyrimidine trpa1 antagonists |
12/10/2009 | WO2009146696A1 Use of indole-3-carboxylic esters for inhibiting microsomal prostaglandin e2 synthase |
12/10/2009 | WO2009129149A3 Drug depots having different release profiles for reducing, preventing or treating pain and inflammation |
12/10/2009 | WO2009129147A3 Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation |
12/10/2009 | WO2009120484A3 Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin |
12/10/2009 | WO2009117640A3 Antibodies against interleukin-10 like cytokines and uses therefor |
12/10/2009 | WO2009112488A3 Polyether polyol dendron conjugates with effector molecules for biological targeting |
12/10/2009 | WO2009111681A3 Gallium compounds and methods of use to treat inflammatory bowel disease |
12/10/2009 | WO2009109850A3 N-substitutedbenzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation |
12/10/2009 | WO2009109618A3 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 |
12/10/2009 | WO2009109613A3 1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1 |
12/10/2009 | WO2008109498A8 Nucleic acid compounds for inhibiting hdac gene expression and uses thereof |
12/10/2009 | WO2007096782A3 Compositions for disorders associated wtth metachromatic cell activation |
12/10/2009 | US20090306579 Delivery of corticosteroids through iontophoresis |
12/10/2009 | US20090306407 Pyrrolidine analogue for preventing neurogenic pain and method for production thereof |
12/10/2009 | US20090306185 Nanogenomics for medicine: siRNA engineering |
12/10/2009 | US20090306155 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases |
12/10/2009 | US20090306141 Novel Compounds |
12/10/2009 | US20090306129 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
12/10/2009 | US20090306122 Substituted tetrahydropyrroloquinoline derivatives as kinase modulators, especially of tyrosine and raf kinases |
12/10/2009 | US20090306108 Substituted pyrimidinones |
12/10/2009 | US20090306104 Use of Lck inhibitors for treatment of immunologic diseases |
12/10/2009 | US20090306082 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
12/10/2009 | US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
12/10/2009 | US20090306074 Thiazolidinedione derivatives as p13 kinase inhibitors |
12/10/2009 | US20090306072 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes |
12/10/2009 | US20090306070 Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use |
12/10/2009 | US20090306069 Azolidinone-vinyl fused-benzene derivatives |
12/10/2009 | US20090306041 Inhibitors of Bruton's tyrosine kinase |
12/10/2009 | US20090306032 Use of solid lipid nanoparticles Comprising Cholesteryl Propionate and/or Cholesteryl Butyrate |
12/10/2009 | US20090306028 Compositions and methods for treating inflammatory disorders |
12/10/2009 | US20090306001 Novel amphiphilic derivatives of alpha-c-phenyl-n-tert-butylnitrone |
12/10/2009 | US20090305985 Immunomodulatory Agents For Treatment of Inflammatory Diseases |
12/10/2009 | US20090305961 Novel chimeric plasminogen activators and their pharmaceutical use |
12/10/2009 | US20090305365 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
12/10/2009 | US20090304793 Sustained release opioid formulations and methods of use |
12/10/2009 | US20090304648 Mast Cell Stabilizers to Prevent or Treat Laminitis |
12/10/2009 | US20090304603 Topical steroid spray with botanic seed oils |
12/10/2009 | DE102009012465A1 Pharmazeutische Zusammensetzung zur Prophylaxe und Behandlung der Arteriosklerose, sowie zur Schmerzbekämpfung und zur Entzündungshemmung A pharmaceutical composition for the prophylaxis and treatment of atherosclerosis, as well as pain relief and inflammation |
12/10/2009 | DE102008027331A1 Verwendung von Indol-3-carbonsäureestern zur Hemmung der mikrosomalen Prostaglandin E2 Synthase The use of indole-3-carboxylic acid esters to inhibit the microsomal prostaglandin E2 synthase |
12/10/2009 | CA2726917A1 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
12/10/2009 | CA2726885A1 Sirna of human osteopontin |
12/10/2009 | CA2726878A1 Novel treatments |
12/10/2009 | CA2726193A1 Methods of treating inflammatory intestinal disease and managing symptoms thereof |
12/10/2009 | CA2725628A1 Analgesic effects of peptide toxin apetx2 |
12/10/2009 | CA2724878A1 3,4-dihydropyrimidine trpa1 antagonists |
12/09/2009 | EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
12/09/2009 | EP2130829A1 Novel hydroxyindole derivative |
12/09/2009 | EP2130828A1 Sulfonamide derivative |
12/09/2009 | EP2130823A1 Compound that is a dual inhibitor of enzymes pde7 and/or pde4, pharmaceutical compositions and uses thereof |
12/09/2009 | EP2130820A1 Antipruritics |
12/09/2009 | EP2130547A1 IL-25 for use in the treatment of inflammatory diseases |
12/09/2009 | EP2130537A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
12/09/2009 | EP2130536A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
12/09/2009 | EP2129673A1 Amimomethyl azaadamantane derivatives and use thereof as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (nnrs) |
12/09/2009 | EP2129661A1 Quinoline derivatives as crth2 receptor ligands |
12/09/2009 | EP2129402A2 Receptor and antigen targeted prodrug |
12/09/2009 | EP1554256B1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
12/09/2009 | EP1519939B1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
12/09/2009 | EP1518517B1 Drug-delivery endovascular stent |
12/09/2009 | EP1392642B1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
12/09/2009 | EP1300401B1 Thiazole derivatives for use as antiinflammatories |
12/09/2009 | EP1252144B1 Substituted glutarimides and use thereof il-12 production inhibitors |
12/09/2009 | EP1020179B1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
12/09/2009 | CN101600697A New phenyl- (4-phenyl-pyrimidin-2-yl) - amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors |
12/09/2009 | CN101600693A Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases |
12/09/2009 | CN101600683A Therapeutic compounds |
12/09/2009 | CN101600426A Isosorbide mononitrate derivatives for the treatment of intestinal disorders |
12/09/2009 | CN101600425A Isosorbide mononitrate derivatives for the treatment of ocular hypertension |
12/09/2009 | CN101597337A Conjugate of hydroxyalkyl starch and an active agent |
12/09/2009 | CN101597321A LHRH antagonist with long-acting low-histamine release side effect |
12/09/2009 | CN101597292A 2, 4, 6 substituent-pyridino-(3, 2-d) pyridine derivates and application thereof |
12/09/2009 | CN101597272A Sodium salt compound of Iguratimod, preparation method thereof and pharmaceutical use thereof |
12/09/2009 | CN101597271A Iguratimod derivatives, preparation method thereof and pharmaceutical use thereof |
12/09/2009 | CN101597262A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
12/09/2009 | CN101596289A Chinese patent medicine for treating rheumatism and preparation method thereof |
12/09/2009 | CN101596244A External-use medicine for treating rheumatism rheumatoid arthritis |
12/09/2009 | CN101596226A Preparation method of epimedium total flavonoids |
12/09/2009 | CN101596223A Method for enriching ginkgetin compound |
12/09/2009 | CN101596221A Process for preparing water-soluble ginkgo biloba extract used for injection |
12/09/2009 | CN101596205A Antiphlogistic medicinal composition and preparation method thereof |
12/09/2009 | CN101596184A Application of rosmarinic acid as peroxynitrite inhibitor |